Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effects of growth hormone treatment in adults with partial growth hormone deficiency on inflammatory markers and lipids
2005-004478-26Phase 2Terminated
- Sponsor
- Karolinska University Hospital
- Start
- Oct 2005
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2, single-arm trial of somatropin in growth hormone deficiency (GHD) and pituitary neoplasm, sponsored by Karolinska University Hospital. Primary endpoints: Change in inflammatory parameters at 6 months, Change in blood lipid parameters and 1 more. Started Oct 2005; status: terminated.
02
Drugs
somatropin
03
Conditions
growth hormone deficiency (GHD)pituitary neoplasm
Beyond the preview
Go deeper on 2005-004478-26.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-004478-26.